Capital Fund Management S.A. Haemonetics Corp Transaction History

Capital Fund Management S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $61,147 - $75,985	-966 Reduced 5.46%	16,728 $1.24 Billion
Q2 2022 Aug 12, 2022	BUY	$49.27 - $66.08 $871,783 - $1.17 Million	17,694 New	17,694 $1.15 Million
Q4 2019 Feb 13, 2020	SELL	$114.37 - $129.46 $1.77 Million - $2.01 Million	-15,493 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$117.16 - $138.52 $2.04 Million - $2.41 Million	-17,404 Reduced 52.9%	15,493 $1.95 Million
Q2 2019 Aug 12, 2019	SELL	$81.74 - $120.34 $1.72 Million - $2.53 Million	-21,004 Reduced 38.97%	32,897 $3.96 Million
Q1 2019 May 13, 2019	SELL	$83.25 - $102.12 $97,319 - $119,378	-1,169 Reduced 2.12%	53,901 $4.72 Million
Q4 2018 Feb 13, 2019	SELL	$90.66 - $116.63 $9.04 Million - $11.6 Million	-99,685 Reduced 64.41%	55,070 $5.51 Million
Q3 2018 Nov 14, 2018	BUY	$89.96 - $114.58 $4.85 Million - $6.18 Million	53,896 Added 53.44%	154,755 $17.7 Million
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $7.21 Million - $9.66 Million	100,859 New	100,859 $9.05 Million

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.